Genfit SA logo
Genfit SA GNFT
report update icon

Annual report 2024
added 04-25-2026

Genfit SA Net Income | GNFT

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Genfit SA

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 67.3 M -101 M -65.1 M -79.5 M -58.6 M -33.7 M -17.1 M -17 M -12.7 M -5.41 M -9.68 M

All numbers in EUR currency

Indicator range from annual reports

Maximum Minimum Average
67.3 M -101 M -30.3 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Biotechnology industry

Issuer Net Income Price % 24h Market Cap Country
BeyondSpring BeyondSpring
BYSI
-1.01 M $ 0.79 2.12 % $ 32.5 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
-168 M $ 2.08 4.0 % $ 209 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
-9.83 M $ 2.14 0.45 % $ 3.52 M israelIsrael
Capricor Therapeutics Capricor Therapeutics
CAPR
-105 M $ 7.78 0.11 % $ 362 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
9.88 M $ 13.94 0.42 % $ 1.25 B usaUSA
C4 Therapeutics C4 Therapeutics
CCCC
-105 M $ 2.99 1.36 % $ 248 M usaUSA
Codexis Codexis
CDXS
-44 M $ 1.39 2.21 % $ 121 M usaUSA
Cerus Corporation Cerus Corporation
CERS
-15.6 M $ 2.34 2.63 % $ 446 M usaUSA
Certara Certara
CERT
-1.6 M $ 10.07 7.59 % $ 1.62 B usaUSA
Cullinan Management Cullinan Management
CGEM
-220 M $ 16.04 3.42 % $ 966 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
35.3 M $ 2.31 0.43 % $ 216 M israelIsrael
Coherus BioSciences Coherus BioSciences
CHRS
168 M $ 1.12 0.86 % $ 131 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
-259 M $ 32.59 2.97 % $ 2.16 B usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
-11.5 M $ 3.41 1.46 % $ 41.6 M israelIsrael
Cellectis S.A. Cellectis S.A.
CLLS
-67.6 M $ 1.41 0.48 % $ 141 M franceFrance
Cellectar Biosciences Cellectar Biosciences
CLRB
-21.8 M $ 1.67 0.56 % $ 4.36 M usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
-15.9 M $ 5.3 0.7 % $ 2.35 M usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
-8.83 M $ 1.11 1.72 % $ 12.5 M usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
63 M $ 21.87 0.05 % $ 692 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
99.7 M $ 122.03 4.99 % $ 12.7 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
-78.5 M $ 5.85 0.16 % $ 77.9 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
-45.9 K $ 1.14 1.79 % $ 76.2 M usaUSA
Curis Curis
CRIS
-7.58 M $ 0.79 0.1 % $ 10.4 M usaUSA
CorMedix CorMedix
CRMD
163 M $ 7.26 0.97 % $ 523 K usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
-582 M $ 57.34 3.45 % $ 5.16 B schweizSchweiz
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
-15.3 M $ 10.74 0.09 % $ 848 M usaUSA
Champions Oncology Champions Oncology
CSBR
-1.18 M $ 4.97 0.61 % $ 68.7 M usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
-17.4 M $ 2.58 0.78 % $ 356 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
-39.7 M $ 0.52 0.4 % $ 5.75 M usaUSA
Cue Biopharma Cue Biopharma
CUE
-26.6 M $ 24.36 1.27 % $ 2.31 B usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
-25.4 M $ 2.42 4.76 % $ 19.4 M usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
-785 M $ 62.7 0.2 % $ 7.53 M usaUSA
Daré Bioscience Daré Bioscience
DARE
-13.4 M $ 0.84 0.04 % $ 9.39 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
-147 M $ 10.44 0.47 % $ 1.46 B franceFrance
DiaMedica Therapeutics DiaMedica Therapeutics
DMAC
-32.8 M $ 8.42 2.31 % $ 396 M usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
-513 M $ 19.91 0.41 % $ 3.44 B usaUSA
Precision BioSciences Precision BioSciences
DTIL
-45.7 M $ 6.31 0.16 % $ 80.9 M usaUSA
Dyadic International Dyadic International
DYAI
-7.36 M $ 0.45 0.31 % $ 16.3 M usaUSA
Editas Medicine Editas Medicine
EDIT
-160 M $ 2.79 6.49 % $ 248 M usaUSA
Edesa Biotech Edesa Biotech
EDSA
-7.19 M $ 3.91 1.3 % $ 22.2 M usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
1.24 B $ 0.36 0.36 % $ 16.5 M israelIsrael
Enanta Pharmaceuticals Enanta Pharmaceuticals
ENTA
-81.9 M $ 12.6 0.93 % $ 269 K usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
-11.4 M $ 2.62 0.69 % $ 121 M israelIsrael
Equillium Equillium
EQ
-22.4 M $ 1.45 2.84 % $ 83.1 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
-4.6 M $ 55.62 0.47 % $ 1.5 B usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
-7.83 M $ 0.4 3.54 % $ 3.15 M israelIsrael
Exelixis Exelixis
EXEL
783 M $ 58.85 0.79 % $ 16 B usaUSA
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
-232 M $ 3.15 0.62 % $ 231 K usaUSA
Fate Therapeutics Fate Therapeutics
FATE
-136 M $ 2.43 4.74 % $ 289 M usaUSA
Fortress Biotech Fortress Biotech
FBIO
37 M $ 2.09 2.96 % $ 58.3 M usaUSA